EICHOR
● Not Yet Recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
About this study
This study is a randomized, open-label, multicenter Phase III clinical trial involving patients with relapsed/refractory multiple myeloma. The estimated total sample size is 260 cases, who will be randomly assigned in a 1:1 ratio to the test group and the control group. The primary objective of the study is to demonstrate the efficacy of TQB2934 for injection compared to the investigator-selected regimen in subjects with relapsed or refractory multiple myeloma (RRMM) by evaluating progression-free survival (PFS).
This description comes directly from the study's public registry record.
Talk to the study team
Peng Liu, Doctor · 18286006744 · liu.peng@zs-hospital.sh.cn
Always discuss trial participation with your own doctor first.
Locations (49)
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, Anhui, China | — |
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | — |
| Beijing Chao-Yang Hospital,Capital Medical University | Beijing, Beijing Municipality, China | — |
| Beijing Jishuitan Hospital,Capital Medical University | Beijing, Beijing Municipality, China | — |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | — |
| The Southwest Hospital of Amu | Chongqing, Chongqing Municipality, China | — |
| Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Central Hospital) | Lanzhou, Gansu, China | — |
| Lanzhou University Second Hospital | Lanzhou, Gansu, China | — |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | — |
| Sun Yat-Sen University Cancer Center | Guangzhou, Guangdong, China | — |
| Zhujiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | — |
| Affiliated Hospital of Guangdong Medical University | Zhanjiang, Guangdong, China | — |
+ 37 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07569757